William K. Harrington, United States Trustee, Region 2, Petitioner v. Purdue Pharma L.P., et al.

  1. May 16, 2024

    3 Big Bankruptcy Cases Still Pending At The Supreme Court

    The U.S. Supreme Court may have declined to hear a challenge to non-debtor litigation stays in mass tort bankruptcies this week in the Chapter 11 case of Georgia-Pacific's asbestos spinoff, but it is still slated to hand down decisions with the potential for wide-reaching impacts to mass torts and beyond this term.

  2. January 08, 2024

    Supreme Court Is Suddenly Embroiled In A Term For The Ages

    When 2024 began, the U.S. Supreme Court's docket — spanning abortion, guns, social media, the modern regulatory system and more — already seemed certain to shake up the nation's cultural and economic landscapes. But now there's also a showdown involving Donald Trump and America's constitutional bedrock, auguring a truly tectonic term.

  3. January 01, 2024

    Retail Cases To Watch In 2024

    A wide variety of cases are likely to keep retail industry attorneys busy in 2024, including high-profile antitrust actions against Amazon and Google, a growing number of greenwashing disputes, and skirmishes between major retailers and their increasingly unionized workforces.

  4. December 04, 2023

    Justice Jackson Skeptical Of Sacklers' Ch. 11 Liability Shield

    As Purdue Pharma LP and its creditors pushed the U.S. Supreme Court on Monday to bless liability releases granted to members of the Sackler family who own it, a skeptical Justice Ketanji Brown Jackson said it was the owners themselves who created the necessity in the first place by withdrawing billions of dollars from the business before its bankruptcy.

  5. December 04, 2023

    Justices Take Cautious Look At Sacklers' Purdue Immunity

    U.S. Supreme Court justices on Monday challenged a bankruptcy watchdog's position that members of the Sackler family shouldn't get a liability shield in Purdue's Chapter 11 plan, focusing discussion on why such immunity might never be appropriate in the most foundational bankruptcy dispute to make it to the high court in several years.

  6. December 01, 2023

    Up Next At High Court: Purdue Pharma, Taxes & Job Transfers

    The U.S. Supreme Court returns Monday for the last argument session of the calendar year to consider whether bankruptcy courts have the authority to sign off on third-party liability releases in Chapter 11 plans, whether Congress can tax unrealized foreign gains, and which standard should be used to determine the viability of employment discrimination claims.

  7. December 01, 2023

    Purdue's High Court Case Puts Bankruptcy Pragmatism On Trial

    Purdue Pharma's oral arguments before the U.S. Supreme Court on Monday are likely to cover several exalted ideas, including the constitutional limits of America's bankruptcy code and the moral implications of letting billionaires off the hook for their company's role in the opioid epidemic. But some experts say the case threatens a humbler factor at the very heart of bankruptcy practice itself: pragmatism.

  8. November 06, 2023

    Justices Grant Purdue Creditors Separate Argument Time

    The U.S. Supreme Court will allow creditors of Purdue Pharma LP to make their own oral arguments in a case that asks whether the U.S. Bankruptcy Code authorizes as part of a Chapter 11 plan the release of third-party claims against members of the Sackler family.

  9. October 25, 2023

    First Nations Group Asks High Court To Nix Sackler Releases

    A Canadian First Nations group Wednesday asked the U.S. Supreme Court to overturn the liability releases granted to Purdue Pharma's former owners in the opioid maker's Chapter 11 plan, saying their communities have been "shattered" by opioid sales.

  10. October 23, 2023

    High Court Told Purdue's Ch. 11 Liability Waiver Is Legal

    Purdue Pharma and parties to its Chapter 11 proceedings urged the U.S. Supreme Court to uphold a deal releasing the Sacklers from civil claims in exchange for their contributing at least $5.5 billion to the bankruptcy estates for victim compensation and opioid abatement, saying the liability releases are permitted by the U.S. Bankruptcy Code.